ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,287 Cr | ₹1,165 Cr | ₹1,137 Cr | ₹1,144 Cr | ₹150 Cr |
What is the latest Contingent Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1,287 Cr |
| Mar2025 | ₹1,165 Cr |
| Mar2024 | ₹1,137 Cr |
| Mar2023 | ₹1,144 Cr |
| Mar2022 | ₹150 Cr |
How is Contingent Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,287 Cr | 10.52 | |
| Mar2025 | ₹1,165 Cr | 2.44 | |
| Mar2024 | ₹1,137 Cr | -0.61 | |
| Mar2023 | ₹1,144 Cr | 661.47 | |
| Mar2022 | ₹150 Cr | - | |
Compare Contingent Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,165.0 Cr | -2.1% | 14.8% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -2.1% |
14.8% |
-8.5% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses